Skip to main content
Clinical Trials/NCT00486941
NCT00486941
Completed
Phase 3

A Randomized Trial of Lifestyle Intervention in Primary Health Care for the Modification of Cardiovascular Risk Factors - the Björknäs Study

Umeå University1 site in 1 country151 target enrollmentFebruary 2003

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Hypertension
Sponsor
Umeå University
Enrollment
151
Locations
1
Primary Endpoint
Changes in anthropometry (BMI, waist and hip cf)
Status
Completed
Last Updated
18 years ago

Overview

Brief Summary

The purpose of this study is to determine whether a short group intervention programe aiming at lifestyle changes at a local health centre can improve risk factors for cardiovascular disease

Detailed Description

Successfully transferring the findings of expensive and tightly controlled lifestyle intervention programmes to the primary care setting is necessary if such knowledge is to be used for disease prevention at the population level. Therefore, our objective was to evaluate the efficacy of a lifestyle intervention programe in the primary health care setting, targeted at patients with moderate- to high-risk of cardiovascular disease according to cardiovascular risk factor levels, physical activity and quality of life ratings. Randomised controlled trial with follow-up at 3, 12, 24 and 36 months, carried out in a primary health care centre in Northern Sweden. A total of 151 middle-aged men and women, with hypertension, dyslipidemia, type 2 diabetes or obesity were enrolled. The subjects were randomised to an intervention (n = 75) or control group (n = 76). 120 subjects completed the three-year follow-up. The intervention was based on the protocols used in the Finnish Diabetes Prevention study (DPS) and the U.S Diabetes Prevention Program

Registry
clinicaltrials.gov
Start Date
February 2003
End Date
March 2006
Last Updated
18 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients from one single health care centre with a diagnosis of:
  • Typ 2 diabetes,
  • Hypertension,
  • Obesity or
  • Dyslipidemia

Exclusion Criteria

  • Coronary heart
  • BP \>180/105,
  • Dementia; or
  • Severe psychiatric disease

Outcomes

Primary Outcomes

Changes in anthropometry (BMI, waist and hip cf)

Time Frame: 3 years

Maximal oxygen uptake (VO2max)

Time Frame: 3 years

Health-related quality of life (EQ 5D, SF-36)

Time Frame: 3 years

Self-reported physical activity

Time Frame: 3 years

Secondary Outcomes

  • Total cholesterol, HDL and triglycerides(3 years)
  • Glucose tolerance (OGTT)(3 years)
  • Blood pressure(3 years)

Study Sites (1)

Loading locations...

Similar Trials